ReviewVeterinarni medicina2026
Antimicrobial resistance in veterinary medicine: Mechanisms, regulation and control strategies.
Review in Veterinarni medicina, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) represents a major global threat to both human and animal health. Within the One Health framework, farm and wild animals serve as critical reservoirs of resistant bacteria and resistance genes, which can disseminate through food, water, and the environment. The excessive and inappropriate use of antibiotics in veterinary medicine exerts selection pressure that fosters the emergence and spread of antimicrobial resistance. Current mitigation strategies aim to reduce antibiotic consumption and promote prudent use through hygiene measures, vaccination, individualised therapy, pharmacokinetic-pharmacodynamic (PK/PD) dosing optimisation, and comprehensive AMR monitoring. European legislation (EU Regulations 2019/4 and 2019/6) provides stringent guidelines on antibiotic prescription, usage, and residue limits. In this context, antibiotic combination therapy represents a promising approach to enhance antimicrobial efficacy, broaden the antibacterial spectrum, and suppress the emergence of resistance by targeting multiple bacterial pathways simultaneously. In addition to developing new drugs, renewed focus on reviving older antimicrobial molecules
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.